PharmiWeb

ESTEVE to Acquire TerSera Therapeutics’ Infusion Specialty Therapies Business Unit, Expanding U.S. Presence

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...
The Manila Times

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

Amyotrophic Lateral Sclerosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Helixmith, Sanofi, Denali Therapeutics, Transposon Th…

In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.
pharmaphorum

Novartis cleared to restart trials of new Zolgensma delivery route

The FDA has relaxed a clinical hold on clinical trials of Novartis' intrathecal formulation of spinal muscular atrophy (SMA) gene therapy Zolgensma, allowing a new phase 3 trial to get underway.
verywellhealth

Colectomy (Colon Resection Surgery): What You Need to Know

A colectomy is a major surgery that takes weeks to recover from. Potential risks can include infection and organ damage. In a partial colectomy, the diseased part of the colon is removed, and the ...